How GLP-1 Medications Affect Blood Pressure in Patients with Hypertension Weight loss often leads to a decreased need for blood pressure medications, which can pose risks for patients who are currently on anti-hypertensive medications (blood pressure pills)
However, the study reported considerable overlap in the plasma concentrations achieved with the different dosages of both formulations
Additional medical conditions The BMI and lifestyle requirements are both non-negotiable for Wegovy coverage, but on top of that, patients must meet one of the following requirements: Other weight loss drugs on the VA formularylike naltrexone/bupropionmust not be tolerated, not successful (less than 5% weight reduction), or medically inadvisable (with rationale)
PloS Pathog (2012) 8(10):e1002996
Combining Tirzepatide With Lifestyle Changes Tirzepatide enhances weight loss when combined with consistent physical activity, though the medication itself produces meaningful results even with modest lifestyle changes
Semaglutide and Tirzepatide Basics Semaglutide is a medication from the class of glucagon-like peptide-1 (GLP-1) receptor agonists (more on that in a bit!)
